Back to AUTL

MARSHALL WACE, LLP → AUTL

MARSHALL WACE, LLP AUTL Position History

Autolus Therapeutics plc • Healthcare

Quarters held
13
Latest value
$151K
Q2 2026
Peak value
$6.6M
First seen
Q2 2023

Dollar value over time

Show data table
PeriodPosition value
Q2 2023$61K
Q4 2023$3.2M
Q1 2024$6.6M
Q2 2024$2.6M
Q3 2024$2.7M
Q4 2024$1.8M
Q1 2025$14K
Q1 2025$947K
Q3 2025$88K
Q3 2025$958K
Q4 2025$538K
Q1 2026$37K
Q2 2026$151K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$151K94.7K——
Q1 2026$37K26.7K——
Q4 2025$538K270.3K——
Q3 2025$958K587.9K——
Q3 2025$88K54.1K——
Q1 2025$947K611.1K——
Q1 2025$14K8.8K——
Q4 2024$1.8M757.5K——
Q3 2024$2.7M757.5K——
Q2 2024$2.6M757.5K——
Q1 2024$6.6M1.04M——
Q4 2023$3.2M497.0K——
Q2 2023$61K25.5K——

Other funds holding AUTL

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B